It reduces and improves the field of cancerization associated with actinic keratosis (AK) and non-melanoma skin cancer (NMSC). It creates a protective film on the skin, which prevents the appearance of new lesions and promotes the repair of existing lesions. Its continuous use promotes the natural DNA repair mechanism.

Apply a generous amount to the entire affected area twice a day, in the morning and at midday, as photolyase is activated by visible light. If used in direct sunlight, apply generously to dry skin half an hour before sun exposure. Reapply every 2 hours and after sweating, swimming, or toweling off. Avoid contact with eyes and mucous membranes. In case of an adverse reaction to any of the ingredients, discontinue treatment and consult your doctor. Keep out of the reach and sight of children. There is no data regarding the use of Eryfotona AK-NMSC in children, pregnant women, or breastfeeding women. Shake well before use.

Repairsomes® (UVB-UVA Filter complex+ plankton extract), Bisabolol, Tocopheryl acetate, Panthenol, Excipients qs.

Actinic keratosis and other forms of non-melanoma skin cancer are diseases caused by chronic exposure to sunlight. If you have suffered from AK and NMSC, direct sun exposure should be avoided. Its use is not recommended for children, pregnant women, and during breastfeeding. Avoid contact with eyes and mucous membranes. In case of a possible adverse reaction to any of the ingredients, discontinue treatment and consult a doctor. Keep out of the sight and reach of children. Shake the container before use. Apply only to clean, intact skin. Daily and continuous use is essential to prevent and treat AK and NMSC as an adjunct. In patients undergoing pharmacological or surgical treatment for AK or NMSC, start treatment with Eryfotona® AK-CPNM after the lesions have healed.

Prevents and repairs actinic lesions. ISDIN-LABORATÓRIO FARMACÊUTICO, UNIPESSOAL, LDA